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ABSTRACT
This study investigated the causes of invasive
bacterial infections in children aged <15 years in
St Petersburg, Russia, during 2001–2003, using
culture and antigen detection methods (rapid
antigen latex agglutination (RAL)) for normally
sterile body ﬂuids. A pathogen was detected in 90
cases (culture 50, RAL 40). Neisseria meningitidis
was the most common pathogen (66%), followed
by Haemophilus inﬂuenzae (19%) and Streptococcus
pneumoniae (16%). Meningitis was the main clin-
ical diagnosis (68 ⁄ 90, 76%), with N. meningitidis
serogroup B, H. inﬂuenzae type b (Hib), and
S. pneumoniae serogroup 1 being the most com-
mon isolates. Hib was less prevalent in St Peters-
burg than it was in industrialised countries before
the introduction of Hib vaccinations.
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Neisseria meningitidis, Haemophilus inﬂuenzae
type b (Hib) and Streptococcus pneumoniae are the
main bacterial pathogens that cause invasive
infections such as meningitis, sepsis and pneu-
monia in children aged <5 years. The aim of this
exploratory study was to investigate the occur-
rence of bacterial pathogens causing invasive
infections among children aged <15 years in St
Petersburg, Russia, in order to help evaluate the
need for vaccination against meningococcus, Hib
and pneumococcus as part of the national immu-
nisation programme.
The study was performed between 1 April 2001
and 31 March 2003. Three of the nine hospitals for
children and adolescents in St Petersburg partic-
ipated, namely the Institute of Children’s Infec-
tious Diseases (ICID), City Hospital no. 4, and
City Hospital no. 2. All invasive childhood infec-
tions in St Petersburg are treated in one of these
three hospitals. The study protocol was approved
by the Ethical Committee of the ICID and
informed consent was obtained verbally from
the children’s guardians.
The study included all children aged <15 years
who were admitted to the participating hospitals
with symptoms suggestive of bacterial meningitis,
septicaemia, pneumonia, epiglottitis, bacterial
arthritis or cellulitis, as described in the WHO
generic protocol for population-based surveillance
of H. inﬂuenzae type b [1]. Details of the case
deﬁnitions used are listed in Table 1. Standard
bacteriological methods were used according to
WHO recommendations [1] and the ofﬁcial pro-
tocols in Russia. Isolates of N. meningitidis and
H. inﬂuenzae were serotyped using slide aggluti-
nation. The presence of antigens in cerebrospinal
ﬂuid (CSF) or blood to N. meningitidis (sero-
groups A, B and C), Hib and pneumococcus
was detected using rapid antigen latex agglutina-
tion (RAL) tests (Slidex meningite-Kit 5; bio-
Me´rieux, Marcy l¢Etoile, France). All isolates of
N. meningitidis, H. inﬂuenzae and S. pneumoniae
were identiﬁed and serotyped for quality assur-
ance at the National Public Health Institute (KTL),
Oulu, Finland as described previously [2–4]. Bac-
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terial identiﬁcation and serogroup ⁄ type results
obtained by the ICID and KTL were compared.
If discrepancies were detected, the result obtained
at the KTL was considered to be deﬁnitive.
In total, 270 patients were admitted with
clinical symptoms of invasive bacterial infection
(248 with an admission diagnosis of meningo-
encephalitis, 20 with pneumonia, and two with
epiglottitis). In 164 (61%) cases, the case-deﬁni-
tion criteria were met. In 90 (55%) of the 164
cases, laboratory results conﬁrmed the aetiology
of infection (Table 1). In total, 74% of the labora-
tory-conﬁrmed cases were aged <5 years
(Table 2). The main clinical manifestation was
meningitis in 68 (76%) of 90 children, regardless
of age. In young children (aged <5 years, n = 51),
meningitis was caused by N. meningitidis in 30
(59%) cases, by H. inﬂuenzae (12 type b, two non-
encapsulated) in 14 (27%) cases, and by S. pneu-
moniae in seven (14%) cases. In older children,
meningitis was caused mainly by N. meningitidis
(12 ⁄ 17, 71%) and by S. pneumoniae (5 ⁄ 17, 29%).
None of the cases of meningitis in older children
was caused by H. inﬂuenzae.
Laboratory-conﬁrmed septicaemia was caused
mainly by N. meningitidis. In addition, there were
many cases of clinical meningococcal septicaemia.
Very few cases of pneumonia and epiglottitis
were laboratory-conﬁrmed (Table 1). Among the
90 laboratory-conﬁrmed cases, the pathogen was
cultured in 50 (56%) cases, and gave a positive
result according to RAL in 40 (44%) cases. The
majority (66%) of cases were caused by N. men-
ingitidis, followed by H. inﬂuenzae (19%) and
S. pneumoniae (16%). Group B was the most com-
mon (66%) serogroup among meningococci, sero-
type b was most common (78%) among
H. inﬂuenzae, and serotype 1 was most common
(70%) among pneumococci. H. inﬂuenzae was
detected mainly in CSF, half by culture and half
by RAL. In contrast, 68% of the meningococci
were isolated from blood, half by culture and half
by RAL. Pneumococci were isolated mainly (71%)
by culture from CSF (Table 1).
In the present study, N. meningitidis was the
most common pathogen causing invasive bacte-
rial disease in children, with group B being the
most common serogroup. This is in accord with
a European study in 1999–2000 which revealed
that serogroups B and C accounted for 95% of
cases of disease, with serogroup B predomi-
nating (http://www.hpa.org.uk/hpa/inter/
m_surveillance9900.pdf). However, group A
meningococcus remained more common (>10%
of cases) in the Moscow area in 1999–2000 than
in Europe generally (0.3%), although it has now
Table 1. Deﬁnite, probable and possible cases of meningitis, septicaemia, epiglottitis and pneumonia among 164 children
aged <15 years in St Petersburg, Russia
Diagnosisa
Deﬁnite (n = 50) Probable (n = 40)
Possible (n = 74) All (n = 164)CSF (n = 22) Blood (n = 28) CSF (n = 19) Blood (n = 21)
Meningitis and ⁄ or septicaemia
Haemophilus inﬂuenzae 6b 1c 7c 1c 15
Neisseria meningitidis 10 21 9 19 59
Streptococcus pneumoniae 6 3 3 1 13
No aetiological agent detected 46 46
Clinical meningococcal septicaemia 18 18
Epiglottitis
Haemophilus inﬂuenzae 2c 2
Pneumonia
Streptococcus pneumoniae 1 1
No aetiological agent detected 10 10
CSF, cerebrospinal ﬂuid.
a Case deﬁnitions: (i) deﬁnite cases had a positive CSF or blood culture; (ii) probable cases were positive for bacterial antigen in CSF or blood; (iii) possible cases had no
aetiological agent identiﬁed and the diagnosis was based on clinical signs and biochemical markers of infection.
bSerotype b, 4; non-capsulated, 2.
cSerotype b.
Table 2. Distribution of bacterial pathogens, grouped
according to age, of 90 children with positive blood or









£3 months 1 4 2 7
4–6 months 3 5 1 9
7–12 months 2 11 4 17
1 to <5 years 10 23 1 34
‡5 to <15 years 1 16 6 23
Total 17 59 14 90
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become rare [5]. In Finland, there was an
epidemic of group A meningococcal disease in
the early 1970s which was controlled by a
national vaccination campaign [6].
The present study revealed that Hib was less
common than N. meningitidis as the cause of
meningitis. In an earlier study from Russia, Hib
was responsible for bacterial meningitis in 50% of
cases in St Petersburg, and in about 30% of cases
in Moscow, Ekathenburg and Arkhangelsk [7]. In
Finland, the incidence of meningitis caused by
Hib increased several-fold between 1939 and 1986
[8], to 52 ⁄ 100 000 in children aged <5 years [9].
An increasing trend was also reported in other
Nordic countries in recent decades [10], coincid-
ing with an improvement in the socio-economic
conditions since the 1940s. However, meningitis
and other invasive diseases caused by Hib in
Nordic and other European countries almost
disappeared after introduction of the Hib conju-
gate vaccines in the late 1980s or early 1990s
[11–14]. However, a study from Moscow [15], as
well as the present study, suggests that invasive
Hib disease is less prevalent in Russia than was
formerly the case in Nordic countries before the
introduction of Hib vaccination.
Of the three pathogens detected, S. pneumoniae
was the least common in St Petersburg. Unlike in
most Western countries [16], serotype 1 was the
most common serotype. This serotype is known to
cause outbreaks, and ‘endemic’ serotype 1 infec-
tions could actually represent unidentiﬁed
outbreaks [17].
Although this study was performed in three
hospitals in which all paediatric cases of bacterial
infection are supposed to be treated, it is possible
that some cases of meningitis were treated in
other hospitals, and that many cases of pneumo-
nia could have been treated at home. Moreover, it
is not known how many patients with potential
invasive bacterial infections received antibiotics
before hospitalisation. Nevertheless, in view of
these results, general childhood Hib and pneu-
mococcal vaccinations do not appear to be a high
priority for St Petersburg.
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ABSTRACT
Test parameters and clinical impact of the direct
tube coagulase test (DTCT) for rapid identiﬁca-
tion of Staphylococcus aureus from blood culture
were investigated. The sensitivity of the DTCT at
4 h using saline dilution was 96%, compared with
93% using serum separator tubes; speciﬁcity was
100% for both methods. Among 32 patients with
S. aureus bacteraemia, treatment modiﬁcations
were based on microbiology results from the
primary source of infection in 12 patients, on a
Gram’s stain from blood culture in seven patients,
and on the DTCT in nine patients. The DTCT is a
valuable adjunct in the routine microbiology
laboratory because of its good performance,
technical simplicity and low cost.
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Staphylococcus aureus bacteraemia is a serious
condition with high rates of mortality and
morbidity [1,2]. In contrast, coagulase-negative
staphylococci isolated from blood often represent
skin contaminants, except in certain clinical con-
ditions [3]. Early reporting of blood culture results
can improve antimicrobial management and de-
crease costs [4–6]. In the case of S. aureus bactera-
emia, patient outcome is poorer if appropriate
treatment is delayed [7,8]. Awide range of tests for
the rapid identiﬁcation of S. aureus have been
applied to blood cultures [9–20], but the direct
tube coagulase test (DTCT) has the advantage that
it is easy to perform in any laboratory, rapid,
ﬂexible in daily use, and inexpensive. The present
study investigated the performance of the DTCT,
using two sample preparation methods, and eval-
uated the impact of rapid identiﬁcation of S. aureus
fromblood cultures on antimicrobialmanagement.
In total, 633 blood cultures (BACTEC; Becton
Dickinson, Franklin Lakes, NJ, USA) containing
Gram-positive cocci in clusters upon micro-
scopical examination were received at the micro-
biology laboratory of the University Medical
Centre Nijmegen, The Netherlands, between
October 2005 and March 2006. Blood culture
bottles with growth detected between 14.00 and
17.00 hours on weekdays and between
14.00 hours on Fridays and closure of the labora-
tory on Sundays were excluded from this study,
since readings of the DTCT at 2 and 4 h would fall
outside regular working hours. Blood cultures
collected routinely from patients in the adult
haematology wards or attending the paediatric
oncology outpatient clinic were also excluded
because of the high rate of contaminated cultures
in these settings.
For DTCTs using serum separator tubes (SSTs),
blood culture broth (8.5 mL) from positive blood
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